Primary |
Hypertension |
52.5% |
Product Used For Unknown Indication |
10.5% |
Drug Use For Unknown Indication |
5.8% |
Blood Pressure |
3.1% |
Diabetes Mellitus |
3.1% |
Coronary Artery Disease |
2.7% |
Dementia Alzheimer's Type |
2.3% |
Ill-defined Disorder |
2.3% |
Pain |
2.3% |
Diarrhoea |
1.9% |
Blood Pressure Abnormal |
1.6% |
Depression |
1.6% |
Myocardial Infarction |
1.6% |
Myocardial Ischaemia |
1.6% |
Blood Pressure Increased |
1.2% |
Cardiogenic Shock |
1.2% |
Constipation |
1.2% |
Disbacteriosis |
1.2% |
Multiple Sclerosis |
1.2% |
Type 2 Diabetes Mellitus |
1.2% |
|
Drug Ineffective |
14.4% |
Cough |
10.0% |
Anaemia |
8.9% |
Medication Residue |
7.8% |
Headache |
5.6% |
Hypersensitivity |
5.6% |
Hypertension |
5.6% |
Weight Increased |
5.6% |
Death |
4.4% |
Dizziness |
4.4% |
Drug Hypersensitivity |
3.3% |
Malaise |
3.3% |
Respiratory Arrest |
3.3% |
Toxic Epidermal Necrolysis |
3.3% |
Vomiting |
3.3% |
Alopecia |
2.2% |
Blood Glucose Increased |
2.2% |
Blood Magnesium Increased |
2.2% |
Coeliac Disease |
2.2% |
Diabetes Mellitus |
2.2% |
|
Secondary |
Hypertension |
37.1% |
Product Used For Unknown Indication |
12.7% |
Coronary Artery Disease |
12.4% |
Blood Pressure Abnormal |
5.5% |
Drug Use For Unknown Indication |
4.4% |
Myocardial Infarction |
2.9% |
Prostatic Disorder |
2.9% |
Cardiac Disorder |
2.5% |
Dementia |
2.5% |
Cardiac Failure |
2.2% |
Depression |
1.8% |
Diabetes Mellitus |
1.8% |
Myocardial Ischaemia |
1.8% |
Pain |
1.8% |
Anxiety |
1.5% |
Hiv Infection |
1.5% |
Hyperlipidaemia |
1.5% |
Amnesia |
1.1% |
Blood Pressure Increased |
1.1% |
Nervous System Disorder |
1.1% |
|
Drug Ineffective |
13.3% |
Weight Increased |
10.0% |
Completed Suicide |
6.7% |
Death |
6.7% |
Blood Pressure Inadequately Controlled |
5.0% |
Cough |
5.0% |
Drug Hypersensitivity |
5.0% |
Respiratory Arrest |
5.0% |
Tinnitus |
5.0% |
Vitamin D Decreased |
5.0% |
Blood Cholesterol Increased |
3.3% |
Blood Pressure Increased |
3.3% |
Disorientation |
3.3% |
Dizziness |
3.3% |
Hypertension |
3.3% |
Muscle Spasms |
3.3% |
Pain In Extremity |
3.3% |
Product Quality Issue |
3.3% |
Renal Failure Chronic |
3.3% |
Supraventricular Tachycardia |
3.3% |
|
Concomitant |
Drug Use For Unknown Indication |
24.2% |
Product Used For Unknown Indication |
19.8% |
Hypertension |
15.0% |
Rheumatoid Arthritis |
7.1% |
Diabetes Mellitus |
4.7% |
Type 2 Diabetes Mellitus |
3.9% |
Blood Cholesterol Increased |
3.2% |
Blood Pressure |
3.2% |
Depression |
2.5% |
Multiple Sclerosis |
2.3% |
Atrial Fibrillation |
2.2% |
Pain |
2.2% |
Osteoporosis |
1.8% |
Anxiety |
1.3% |
Gastrooesophageal Reflux Disease |
1.2% |
Hormone Replacement Therapy |
1.2% |
Cardiac Disorder |
1.1% |
Hypercholesterolaemia |
1.1% |
Multiple Myeloma |
1.1% |
Anaemia |
1.0% |
|
Weight Decreased |
16.1% |
Weight Increased |
7.7% |
Drug Ineffective |
6.5% |
Pruritus |
6.5% |
Myocardial Infarction |
5.8% |
Vomiting |
5.8% |
Tachycardia |
4.5% |
White Blood Cell Count Decreased |
4.5% |
Death |
3.9% |
Drug Dose Omission |
3.9% |
Nausea |
3.9% |
Syncope |
3.9% |
Tremor |
3.9% |
Ventricular Tachycardia |
3.9% |
Burning Sensation |
3.2% |
Feeling Hot |
3.2% |
Flushing |
3.2% |
Headache |
3.2% |
International Normalised Ratio Increased |
3.2% |
Malaise |
3.2% |
|
Interacting |
Drug Use For Unknown Indication |
33.3% |
Erectile Dysfunction |
33.3% |
Low Density Lipoprotein Increased |
33.3% |
|
|